Aisling Capital
Venture capitalNew York ยท SeedโSeries C
Investment thesis
Aisling Capital invests in companies developing and commercializing important and innovative healthcare products, services, and technologies. The firm has a long track record spanning over two decades of identifying and supporting healthcare innovation across the biotechnology and medical technology sectors.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 19 of 119 portfolio companiesBiotech ร19Medical Devices ร15Healthtech ร14Advanced Manufacturing ร1AI & Machine Learning ร1Digital Health ร1FemTech ร1
HQs:United Statesร4Denmarkร1Vietnamร1
Investments ยท showing 60 of 119
founders shown can be your intro pathAclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases. The company's clinical and preclinical pipeline includes candidates in development for severe asthma, atopic dermatitis, and T-cell-mediated autoimmune conditions.
BiotechHealthtechMedical Devices
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusionยฎ transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
BiotechFemTechHealthtech
Pfizer discovers, develops, manufactures, and distributes pharmaceutical medicines and vaccines across therapeutic areas including oncology, cardiology, immunology, and infectious diseases. The company serves patients, healthcare professionals, and consumers globally through its research, development, and commercial operations.
BiotechHealthtechMedical DevicesNew York, US
Charles PfizerCharles Erhart
Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases. The company focuses on long-acting therapeutic formulations to address endocrine and rare disease indications.
BiotechHealthtechMedical DevicesDenmark, DK
Jan Mรธller Mikkelsen(Founder, President and Chief Executive Officer)
Biohaven is a biopharmaceutical company focused on discovering and developing treatments in immunology, obesity, neuroscience, and oncology, including approved migraine medications. The company advances therapeutic programs for diseases with significant unmet medical needs.
BiotechHealthtechMedical Devices
CalciMedica is a clinical-stage biopharmaceutical company developing therapies that inhibit CRAC calcium channels to address acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. The company's lead compound targets conditions including acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
BiotechHealthtechMedical Devices
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical Devices
Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.
BiotechHealthtech
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
BiotechDigital HealthHealthtechMedical DevicesFoster City, US
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
BiotechHealthtechMedical Devices
Forge Biologics provides contract manufacturing and process development for AAV-based gene therapies, operating a large-scale cGMP facility with proprietary manufacturing technologies to support developers from early discovery through commercial production.
Advanced ManufacturingBiotechMedical Devices
Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases. The company serves patients, families, and advocates in the rare disease community through novel drug development and patient-centered approaches.
BiotechHealthtechMedical Devices
Jeffrey M. Dayno, M.D.(President and Chief Executive Officer)
Frequently asked questions
- What stage does Aisling Capital invest at?
- Aisling Capital invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Aisling Capital focus on?
- Aisling Capital focuses on Biotech, Healthtech.
- Where is Aisling Capital located?
- Aisling Capital is headquartered in New York, US.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.